Unlocking the Potential of MPO (89 kDa Myeloperoxidase) as a Drug Target and Biomarker

Target Name: MPO

NCBI ID: G4353

Content of Review Report on MPO Target / Biomarker

MPO

Unlocking the Potential of MPO (89 kDa Myeloperoxidase) as a Drug Target and Biomarker

Myeloperoxidase (MPO) is a protein that plays a crucial role in the production of myeloperoxidase-containing products, such as myeloperoxidase-containing extracellular vesicles (MVECs) and myeloperoxidase-containing microvesicles (MVM), which are involved in various cellular processes. MVECs are involved in the production of bone marrow-derived stem cells, while MVM is involved in the production of immune cells. The 89 kDa myeloperoxidase (MPO) is a key enzyme involved in the production of these myeloperoxidase-containing products.

The discovery of MPO as a drug target and biomarker has significant implications for the development of new treatments for various diseases. In this article, we will explore the biology of MPO, its role in disease, and its potential as a drug target and biomarker.

Biography of MPO

Myeloperoxidase is a protein that belongs to the superfamily of 45S rRNA-proteasome subunits. It is expressed in various tissues, including bone marrow, spleen, and peripheral blood. MPO is involved in the production of myeloperoxidase-containing products, such as MVECs and MVM.

MPO is a key enzyme in the production of myeloperoxidase-containing products. The myeloperoxidase-containing products produced by MPO include MVECs and MVM. MVECs are involved in the production of bone marrow-derived stem cells, while MVM is involved in the production of immune cells.

The 89 kDa myeloperoxidase (MPO) is a key enzyme involved in the production of myeloperoxidase-containing products. The 89 kDa subunit is the most abundant isoform of MPO and is expressed in various tissues, including bone marrow, spleen, and peripheral blood. It is involved in the production of myeloperoxidase-containing products, such as MVECs and MVM.

Role of MPO in Disease

MPO is involved in various cellular processes that are essential for the growth, development, and function of the immune system. One of the critical functions of MPO is its role in the production of immune cells, including T cells, B cells, and natural killer cells.

Studies have shown that changes in the levels of MPO have been associated with various diseases, including cancer, autoimmune diseases, and neurodegenerative diseases. For example, high levels of MPO have been observed in various types of cancer, including breast, lung, and ovarian cancer. Similarly, changes in the levels of MPO have been observed in autoimmune diseases, such as rheumatoid arthritis, and neurodegenerative diseases, such as Alzheimer's disease.

In addition to its role in the production of immune cells, MPO is also involved in the production of myeloperoxidase-containing products, which are involved in the production of various signaling molecules that regulate cellular processes, including cell growth, apoptosis, and inflammation.

Potential as a Drug Target

The potential of MPO as a drug target is significant due to its involvement in various cellular processes that are involved in the development and progression of various diseases. High levels of MPO have been observed in various types of cancer, making it an attractive target for cancer therapies.

Studies have shown that inhibiting the activity of MPO can lead to the inhibition of various cellular processes that are involved in the growth, development, and progression of cancer. For example, inhibitors of

Protein Name: Myeloperoxidase

Functions: Part of the host defense system of polymorphonuclear leukocytes. It is responsible for microbicidal activity against a wide range of organisms. In the stimulated PMN, MPO catalyzes the production of hypohalous acids, primarily hypochlorous acid in physiologic situations, and other toxic intermediates that greatly enhance PMN microbicidal activity (PubMed:9922160). Mediates the proteolytic cleavage of alpha-1-microglobulin to form t-alpha-1-microglobulin, which potently inhibits oxidation of low-density lipoprotein particles and limits vascular damage (PubMed:25698971)

The "MPO Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MPO comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets